The Technical Analyst
CM Life Sciences III Inc. [CMLT]
Exchange: NASDAQ Sector: Financial Services Industry: Shell Companies
CM Life Sciences III Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
-5.65% $8.69
America/New_York / 20 des 2021 @ 00:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 4 245.96 mill |
| EPS: | 0 |
| P/E: | 0 |
| Earnings Date: | N/A |
| SharesOutstanding: | 488.60 mill |
| Avg Daily Volume: | 0.351 mill |
| RATING 2022-02-04 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Neutral | |
| Return On Asset: | Neutral | |
| DE: | Sell | |
| P/E: | Strong Buy | |
| Price To Book: | Strong Sell |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE -18.15 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE -25.74 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0 - 0 ( +/- 0.00%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2021-08-01 | Cmls Holdings Iii Llc | Sell | 200 000 | Class B common stock |
| 2021-08-02 | Abernethy Amy | Sell | 200 000 | Class B common stock |
| 2021-04-06 | Cmls Holdings Iii Llc | Sell | 13 700 000 | Class B common stock |
| 2021-04-06 | Robins Chad M | Sell | 25 000 | Class B common stock |
| INSIDER POWER |
|---|
| 0.00 |
| Last 4 transactions |
| Buy: 0 | Sell: 14 125 000 |
Forecast:
01:40 - $8.69
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $8.69 (-5.65% ) |
| Volume | 0.563 mill |
| Avg. Vol. | 0.351 mill |
| % of Avg. Vol | 160.38 % |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For CMLT
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
CMLT
CM Life Sciences III Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.
Last 10 Buy Signals
Latest News
2021-08-06 15:37:38 - Benzinga
Corvex, Casdin Backed SPAC To Merge With EQRx In $1.8B Deal
CM Life Sciences III Inc (NASDAQ: CMLT), the third SPAC backed by Eli Casdin's Casdin Capital LLC and Keith Meister's Corvex Management LP, is set to merge with EQRx Inc (NASDAQ: EQRX). The stock will list on NASDAQ under the EQRX symbol.
2021-08-06 13:34:32 - CNBC Television
Here are the benefits of SPAC deals
Eli Casdin, the chief investment officer of Casdin Capital, joins Keith Meister, CEO of Corvex Management, on the Halftime Report to discuss their SPAC deal with EQRX, a biotechnology company.